Found: 29
Select item for more details and to access through your institution.
Clinical Evidence for Locoregional Surgery of the Primary Tumor in Patients with De Novo Stage IV Breast Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 9, p. 5059, doi. 10.1245/s10434-021-09650-3
- By:
- Publication type:
- Article
The derived neutrophil‐to‐lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 5, p. 908, doi. 10.1111/bjh.16447
- By:
- Publication type:
- Article
Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study.
- Published in:
- Cancer Research & Treatment, 2022, v. 54, n. 4, p. 1038, doi. 10.4143/crt.2021.698
- By:
- Publication type:
- Article
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
- Published in:
- Cancer Research & Treatment, 2019, v. 51, n. 3, p. 919, doi. 10.4143/crt.2018.230
- By:
- Publication type:
- Article
Full-spectral genome analysis of natural killer/T cell lymphoma highlights impacts of genome instability in driving its progression.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01324-5
- By:
- Publication type:
- Article
Benefit of consolidative radiation in patients with extranodal limited-stage diffuse large B-cell lymphoma: a multicenter retrospective study in China.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 10, p. 4231, doi. 10.1007/s00277-024-05855-0
- By:
- Publication type:
- Article
A proposal for a prognostic index for non-nasal type natural killer/T cell lymphoma after asparaginase-based treatment.
- Published in:
- Annals of Hematology, 2020, v. 99, n. 12, p. 2811, doi. 10.1007/s00277-020-04278-x
- By:
- Publication type:
- Article
KIF15 is involved in development and progression of Burkitt lymphoma.
- Published in:
- Cancer Cell International, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12935-021-01967-z
- By:
- Publication type:
- Article
Nanoparticles (NPs)‐Meditated LncRNA AFAP1‐AS1 Silencing to Block Wnt/β‐Catenin Signaling Pathway for Synergistic Reversal of Radioresistance and Effective Cancer Radiotherapy.
- Published in:
- Advanced Science, 2020, v. 7, n. 18, p. 1, doi. 10.1002/advs.202000915
- By:
- Publication type:
- Article
Primary breast diffuse large B‐cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 23, p. 21188, doi. 10.1002/cam4.6686
- By:
- Publication type:
- Article
A study on the prevention of hemorrhage and perforation in patients with primary gastric diffuse large‐B cell lymphoma during treatment with immunochemotherapy.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 6924, doi. 10.1002/cam4.5486
- By:
- Publication type:
- Article
A novel prognostic nomogram for patients with extragastric mucosa‐associated lymphoid tissue lymphoma: A multicenter study.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 18, p. 3407, doi. 10.1002/cam4.4702
- By:
- Publication type:
- Article
Chemotherapy Plus Radiotherapy Versus Chemotherapy Alone for Patients With Peripheral T-Cell Lymphoma, Not Otherwise Specified.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.607145
- By:
- Publication type:
- Article
Characteristics of immunotherapy trials for nasopharyngeal carcinoma over a 15-year period.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1195659
- By:
- Publication type:
- Article
Proposed prognostic subgroups and facilitated clinical decision-making for additional locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: a retrospective study based on recursive partitioning analysis.
- Published in:
- Radiation Oncology, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13014-022-02168-2
- By:
- Publication type:
- Article
EZH1/2 alteration as a potential biomarker for immune checkpoint inhibitors across multiple cancer types.
- Published in:
- Journal of Translational Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12967-023-04759-3
- By:
- Publication type:
- Article
A prognostic 15-gene model based on differentially expressed genes among metabolic subtypes in diffuse large B-cell lymphoma.
- Published in:
- Pathology & Oncology Research, 2023, p. 01, doi. 10.3389/pore.2023.1610819
- By:
- Publication type:
- Article
Liquid biopsy in T-cell lymphoma: biomarker detection techniques and clinical application.
- Published in:
- Molecular Cancer, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12943-024-01947-7
- By:
- Publication type:
- Article
Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review).
- Published in:
- International Journal of Oncology, 2023, v. 63, n. 2, p. N.PAG, doi. 10.3892/ijo.2023.5545
- By:
- Publication type:
- Article
Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A prognostic index for nasal‐type early‐stage extranodal natural killer/T‐cell lymphoma: A multicenter study.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 5, p. E122, doi. 10.1002/ajh.25426
- By:
- Publication type:
- Article
Surgery and Chemotherapy versus Chemotherapy Only in Older Persons with Primary Intestinal Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8831, doi. 10.2147/CMAR.S330273
- By:
- Publication type:
- Article
Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2− Advanced Breast Cancer.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4241, doi. 10.2147/CMAR.S254365
- By:
- Publication type:
- Article
A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 1981, doi. 10.2147/CMAR.S244176
- By:
- Publication type:
- Article
Extranodal natural killer/T-cell lymphoma involving the gastrointestinal tract: analysis of clinical features and outcomes from the Asia Lymphoma study group.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-86
- By:
- Publication type:
- Article
Identifying SLC2A6 as the novel protective factor in breast cancer by TP53-related genes affecting M1 macrophage infiltration.
- Published in:
- Apoptosis, 2024, v. 29, n. 7/8, p. 1211, doi. 10.1007/s10495-024-01964-3
- By:
- Publication type:
- Article
Novel agents and regimens in relapsed or refractory peripheral T-cell lymphoma: latest updates from 2023 ASH annual meeting.
- Published in:
- Experimental Hematology & Oncology, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s40164-024-00510-w
- By:
- Publication type:
- Article
Long-Term Survival of Patients With Chemotherapy-Naïve Metastatic Nasopharyngeal Carcinoma Receiving Cetuximab Plus Docetaxel and Cisplatin Regimen.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.01011
- By:
- Publication type:
- Article
Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-15308-7
- By:
- Publication type:
- Article